Results 251 to 260 of about 2,392,188 (303)

Association Between FTO rs1558902 Polymorphism, Age‐Related Hypogonadism, and Central Obesity in Japanese Men

Andrology, EarlyView.
ABSTRACT Background Obesity and low testosterone levels are closely interconnected, with the FTO gene being the most robust genetic determinant of body mass index (BMI). However, whether this primary genetic driver of obesity directly influences the hypothalamic‐pituitary‐testicular (HPT) axis remains unclear.
Takahiro Tsutsumi, Hideyuki Okuma, Fuminori Kazama, Masumi Endo, Yuna Takato, Hitomi Nara, Asako Miyazaki, Nozomi Harai, Kyoichiro Tsuchiya   +8 more
wiley   +1 more source

D-Ribose Glycation of Human High-Density Lipoprotein: Structural and Functional Alterations. [PDF]

Int J Mol Sci
Morresi C, Tomaso VD, Ricci G, Ferretti G, Bacchetti T.   +4 more
europepmc   +1 more source

Obesity Is an Independent Risk Factor for Oligozoospermia, With Co‐Existing Hyperglycemia Exacerbating Risks of Asthenozoospermia and Elevated Sperm DNA Fragmentation

Andrology, EarlyView.
ABSTRACT Background Metabolic health plays a critical role in maintaining male fertility and may influence offspring health. Therefore, it is necessary to incorporate metabolic indicators into the clinical assessment of male fertility. However, the relationships between different metabolic abnormalities and semen quality remain incompletely understood.
Rubing Hu, Haijiao Zou, Qiaodan Li, Weihong Fan, Jian Xu   +4 more
wiley   +1 more source

Prospective Short‐ and Long‐Term Changes in Cardiometabolic Risk Markers Following Gender‐Affirming Hormone Therapy

Andrology, EarlyView.
ABSTRACT Introduction Gender‐affirming hormone therapy (GAHT) may be associated with increased cardiometabolic disease (CMD) risk. Prospective CMD risk screening is recommended, but long‐term data are needed regarding changes in CMD markers. Objectives To evaluate prospective changes in CMD risk markers during GAHT.
Louise Lehmann Christensen, Camilla Viola Palm, Marianne S. Andersen, Guy T'Sjoen, Jan Frystyk, Tine Taulbjerg Kristensen, Rikke Hjortebjerg, Dorte Glintborg   +7 more
wiley   +1 more source

Plasma Lipoproteins as Key Regulators in Neuropathic Pain: A Comprehensive Review of Mechanisms and Clinical Potential. [PDF]

Pain Ther
Wei H, Shi J, Fan J, Li X, Yang X, Liu Z.   +5 more
europepmc   +1 more source

Lipid Profiles in Breast Cancer: Clinical Associations and Biological Insights. [PDF]

Cancer Diagn Progn
Nikolakopoulou A, Stavrati K, Nastos K, Papaconstantinou D, Michalaki V, Koutroulis G, Dafnios N, Papakonstantinou I, Papadimitriou C.   +8 more
europepmc   +1 more source

Managing remnant cholesterol: role of fenofibrate-statin therapy in reducing triglyceride-rich lipoproteins. [PDF]

Front Cardiovasc Med
Raja V, Aguiar C, Alsayed N, Chibber YS, ElBadawi H, Farnier M, Pushpa K, Tokgözoglu L, Zambon A, Berrou JP, Hermans MP.   +10 more
europepmc   +1 more source

Targeting triglycerides for cardiovascular risk reduction. [PDF]

Intern Emerg Med
Maiorca C, Tramontano D, Di Costanzo A, D'Erasmo L.   +3 more
europepmc   +1 more source

[Effects of aerobic and of strength physical exercises on HDL and LDL lipoproteins and lipoprotein(a)].

Arquivos brasileiros de cardiologia, 2003
Eduardo Seixas, Prado, Estélio Henrique Martin, Dantas   +1 more
openaire   +1 more source